Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Antrocaryon micraster seed extract is a botanical extract derived from the seeds of the *Antrocaryon micraster* tree, a member of the Anacardiaceae family native to tropical rainforests and utilized in African traditional medicine. The extract is rich in polyphenols and phytosterols, which contribute to its demonstrated antiarthritic and antioxidant properties in preclinical models. Research conducted primarily by academic institutions, such as the Centre for Plant Medicine Research in Ghana, indicates that the extract and its aqueous fraction (ASEA) significantly inhibit oxidative stress, protein denaturation, and the infiltration of inflammatory cells. In animal models of rheumatoid arthritis, it has shown efficacy in reducing paw edema, synovium damage, and pannus formation, suggesting potential for development as a natural therapeutic for inflammatory joint diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on antrocaryon micraster seed extract.